Thylacine Biotherapeutics Platform Wins TechConnect World’s Innovation Challenge; ATI’s Mike Stebbins Quoted
Thylacine Biotherapeutics clinched first place in the Medical Threat Reduction Challenge at the TechConnect World conference and expo in Washington, D.C., for its antiviral therapy platform. The Florida-based developer of advanced treatments said Tuesday its THY-01 platform stood out among over 300 submissions at the exhibition sponsored by Advanced Technology International and the Medical CBRN Defense […] More